
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | London | GBP | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GSK | NYSE | USD | Real-time | |
GLAXF | OTC Markets | USD | Delayed | |
GSKN | Mexico | MXN | Delayed | |
GSKy | Frankfurt | EUR | Delayed | |
GSK | Frankfurt | EUR | Delayed | |
GSK | TradeGate | EUR | Delayed | |
GS7 | Xetra | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
Period Ending: | 2022 31/03 |
2021 31/12 |
2021 30/09 |
2021 30/06 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 9780 | 9527 | 9077 | 8092 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 3645 | 3675 | 2822 | 2519 | ||||||||||||||||||||||||||||||
Gross Profit | 6135 | 5852 | 6255 | 5573 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 6979 | 8632 | 7139 | 6453 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 2801 | 895 | 1938 | 1639 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | -203 | -189 | -190 | -169 | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | - | - | -36 | ||||||||||||||||||||||||||||||
Other, Net | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 2598 | 706 | 1748 | 1470 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 431 | -224 | 380 | -68 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 2167 | 930 | 1368 | 1538 | ||||||||||||||||||||||||||||||
Minority Interest | -365 | -181 | -200 | -143 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 1802 | 749 | 1168 | 1395 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | 1802 | 749 | 1168 | 1395 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 1802 | 749 | 1168 | 1395 | ||||||||||||||||||||||||||||||
Dilution Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Diluted Net Income | 1802 | 749 | 1168 | 1395 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 5068 | 5074 | 5060 | 5060 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 0.36 | 0.15 | 0.23 | 0.28 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | 0.14 | 0.23 | 0.19 | 0.19 | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 0.27 | 0.23 | 0.34 | 0.25 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review